|
Richard D. Murdock has over 30 years experience in executive management, fund raising, marketing and business development in the biotech therapeutics and medical device industries. His tenure as CEO includes Sangstat Medical Corporation (acquired by Genzyme), Kyphon and Cellpro, Inc. At Baxter Healthcare, Rick ran the Fenwal Automation Business Unit and later The Fenwal Europe Business Unit. Rick has additional marketing and product development experience in several start-up companies including Hemascience Laboratories, Cytogen, and Haemonetics Corporation. | 